AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.

186.38 11.98 +6.87%
Market cap
$270.5B
P/E
27.6×
Fwd P/E
22.4×
Dividend yield
1.72%
F-score
9/9
Altman Z
3.52
Beneish M
−2.51
Dividend safety
54/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
26.58 28.59 34.41 63.76 386.17 41.06 95.28 44.68 28.82 19.94
Piotroski F-Score
9 6 7 7 5 7 6 4 3 6
P/S ratio
4.63 3.73 4.49 4.76 4.39 4.98 5.39 4.36 3.87 3.05
Altman Z-Score
3.52 2.77 2.69 2.66 1.94 2.31 2.25 1.90 1.80 1.66
Altman Z″-Score (non-manufacturers)
1.80 1.30 0.90 0.65 0.97 1.03 0.52 0.92 0.85 1.12
P/FCF ratio
30.83 27.05 29.43 26.51 37.65 40.77 50.11 26.76 25.41 20.99
Beneish M-Score
(2.51) (2.59) (2.58) (2.75) (2.20) (2.40) (2.59) (2.54) (2.48) (2.74)
P/Operating CF
116.08 69.36 86.44 88.08 115.85 73.70 95.56 43.27 87.10 35.77
Dividend Safety Score
54 — — — — — — — — —
P/B ratio
5.58 4.93 5.25 5.70 4.18 8.47 9.00 6.85 5.22 4.21
EV/Sales
5.00 4.16 4.96 5.25 5.01 5.41 5.85 4.95 4.45 3.52
EV/EBITDA
15.09 13.47 16.73 25.22 24.73 17.34 21.34 15.32 14.91 11.16
EV/FCF
33.32 30.16 32.49 29.25 43.00 44.33 54.42 30.42 29.28 24.25
Current Ratio
0.94 0.93 0.82 0.86 1.16 0.96 0.86 0.96 0.80 0.87
Net Debt/EBITDA
1.13 1.39 1.58 2.36 3.07 1.39 1.69 1.85 1.97 1.50
Debt/Equity
0.57 0.71 0.70 0.76 0.76 1.26 1.20 1.36 1.07 1.01
ROE
22.83% 17.58% 15.63% 8.61% 0.41% 21.14% 9.32% 14.05% 18.02% 19.89%
ROA
9.38% 6.86% 6.03% 3.26% 0.13% 4.99% 2.19% 3.48% 4.77% 5.71%
ROIC
12.15% 9.77% 8.45% 3.99% 1.05% 11.86% 7.06% 7.78% 7.69% 11.12%
Return on Tangible Assets
92.38% 85.66% 152.15% 68.40% 0.87% 42.68% 26.00% 32.07% 68.48% 72.08%
Average Days of Receivables
101.50 100.11 107.98 92.60 100.54 101.28 90.50 95.52 89.90 79.33
Earnings Yield
3.76% 3.50% 2.91% 1.57% 0.26% 2.44% 1.05% 2.24% 3.47% 5.02%
Free Cash Flow Yield
3.24% 3.70% 3.40% 3.77% 2.66% 2.45% 2.00% 3.74% 3.94% 4.76%
Free Cash Flow per Share
5.69 4.81 4.51 5.15 3.08 2.48 2.02 2.84 2.70 2.64
Book value per Share
31.43 26.37 25.28 23.94 27.71 11.92 11.22 11.08 13.15 13.18
Free Cash Flow
8,819.00 7,453.00 6,990.00 7,966.00 4,363.00 3,250.00 2,622.00 3,597.00 3,417.00 3,340.00
EV/EBIT
21.38 22.47 27.72 62.02 177.64 27.91 48.80 32.30 27.21 16.52
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026